<p>美国监管机构正在重新评估婴儿 RSV 抗体治疗，原因是疫苗怀疑者提出的担忧，这导致罗伯特·F·肯尼迪的健康团队启动了安全调查。疾病控制与预防中心（CDC）的免疫实践咨询委员会以 8 票对 3 票的结果投票决定撤回对出生时接种乙型肝炎疫苗的普遍推荐，建议根据个体情况进行决策。如果未接种出生剂量，初始剂量应在婴儿满两个月后再接种。这一审查反映了当前政府对免疫政策的持续重新审视。ACIP 的决定和相关更新可以在 Benzinga.com 上找到。</p>

赛诺菲

赛诺菲集团

阿斯利康

阿斯利康制药

<p>美国监管机构正在重新评估呼吸道合胞病毒（RSV）治疗方案，因为以 RFK Jr.为首的疫苗怀疑者提出了担忧。美国疾病控制与预防中心（CDC）的免疫接种咨询委员会（ACIP）以 8 票对 3 票的结果投票决定取消对出生于阴性母亲的婴儿的普遍乙型肝炎疫苗接种建议，建议采取个体化决策。赛诺菲和阿斯利康正在为 RSV 季节做准备，因为 beyforetus 的产量增加了三倍</p>

<p>U.S. regulators are re-evaluating infant RSV antibody treatments following concerns raised by vaccine skeptics, which led Robert F. Kennedy Jr.'s health team to initiate safety inquiries. The CDC's Advisory Committee on Immunization Practices voted 8-3 to retract the universal recommendation for hepatitis B birth-dose vaccine for infants born to hepatitis B surface antigen-negative mothers and suggested individual-based decision-making. If the birth dose is not administered, the initial dose should be given no earlier than two months of age. This review reflects the ongoing re-examination of immunization policies by the current administration. ACIP's decision and related updates can be found on Benzinga.com.</p>
<div class="lb-trans"><p>美国监管机构正在重新评估婴儿 RSV 抗体治疗，原因是疫苗怀疑者提出的担忧，这导致罗伯特·F·肯尼迪的健康团队启动了安全调查。疾病控制与预防中心（CDC）的免疫实践咨询委员会以 8 票对 3 票的结果投票决定撤回对出生时接种乙型肝炎疫苗的普遍推荐，建议根据个体情况进行决策。如果未接种出生剂量，初始剂量应在婴儿满两个月后再接种。这一审查反映了当前政府对免疫政策的持续重新审视。ACIP 的决定和相关更新可以在 Benzinga.com 上找到。</p>
</div>

US regulators re-evaluating RSV treatment amid concerns from vaccine skeptics led by RFK Jr. CDC recommends individual-based decision-making on hepatitis B vaccine for infants born to negative mothers. ACIP votes 8 to 3 to lift universal recommendation. beyforetus output triples as Sanofi, AstraZeneca gear up for RSV season.